The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumInsights - Products targeting rare diseases are getting lots of publicity following Shire Pharmaceuticals’ (SHRP) announced acquisition of ViroPharma (VRPH), a rare-disease biopharmaceutical company, for $4.2 billion. … Continue Reading
Read nowInsights - It appears that PropThink wasn’t the only firm to notice that ViroPharma’s (VPHM) third quarter results signaled the start of some very promising trends. On … Continue Reading
Read nowResearch - Zogenix (ZGNX) expects to net $56 million from a secondary offering revealed on November 4, $64.4 million with full exercise of the underwriter’s over-allotment option. … Continue Reading
Read nowResearch - When investing in development-stage biotech companies, evidence of success is everything. Therefore, investors should always start with the question: Is the company’s product candidate a … Continue Reading
Read nowInsights - Salix Pharmaceuticals (SLXP) jumped nearly 18% last week on news that it agreed to acquire Santarus, Inc. (SNTS). The combined companies will be the leading … Continue Reading
Read nowRecap - Endo Health Solutions (ENDP) announced plans on Tuesday to purchase Paladin Labs (PLB.TO), a Canadian specialty pharmaceutical manufacturer, for $1.5 billion. ENDP fell significantly in 2012 on … Continue Reading
Read nowInsights - The bad news keeps coming at Coronado Biosciences (CNDO), although based on recent history, the news wasn’t a major surprise. In mid-October, CNDO announced that … Continue Reading
Read now
